A
Arbutus Biopharma Corp
ABUS · NASDAQ · Healthcare · 923M
Price · close
$5.21
+9.22% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
13.0×
Enterprise value / EBITDAEV/EBITDA
-29.8×
Free cash flow yieldFCF yield
-4.0%
Return on equityROE
-43.7%
Operating margin
-192.1%
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
-278.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.